Ads
related to: pfizer covid drug paxlovid rebound dosage recommendations
Search results
Results From The WOW.Com Content Network
Paxlovid is an antiviral that can treat mild to moderate Covid cases for people who are at high risk for severe disease, including hospitalizations or death, according to the U.S. Food and Drug ...
When the antiviral medication Paxlovid was approved in 2021 to treat COVID-19, doctors began noticing a trend among some patients: a rebound case of the virus. After treatment, some people would ...
In May 2022, Pfizer suggested repeating the treatment, but the FDA said there was no evidence of benefit. [43] [44] In June 2022, a US case report of ten people with rebound COVID‑19 had found viral load during relapse was comparable to levels during an initial infection, and high enough to cause secondary transmission. [45]
If symptoms return, FDA says there's "no evidence" taking more Paxlovid helps.
Pfizer’s antiviral pills are highly effective at keeping people with Covid out of the hospital, but in rare cases some may have a rebound. Covid symptoms rebound? Some report relapse after ...
COVID "rebound can occur with or without [Paxlovid] treatment," scientists with the Food and Drug Administration wrote in a study published in December. "Viral RNA rebound was not restricted to ...
Ads
related to: pfizer covid drug paxlovid rebound dosage recommendations